First thyroglobulin level is a predictor of persistent disease in patients with well differentiated follicular thyroid cancer (WDTC)

被引：0
|
作者：
Zakavi, Seyed Rasoul [1 ]
Ghaffari, Azar [1 ]
Mousavi, Zohre [2 ]
机构：
[1] Mashhad Univ Med Sci, Dept Nucl Med, Mashhad, Iran
[2] Mashhad Univ Med Sci, Dept Endocrinol, Mashhad, Iran
来源：
JOURNAL OF NUCLEAR MEDICINE | 2009年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
314
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Ablative Free Thyroxine to Thyroglobulin Ratio as a Predictor of Differentiated Thyroid Cancer Recurrence
    Aron, Margaret
    Cote, Valerie
    Tamilia, Michael
    Hier, Michael
    Black, Martin J.
    Zhang, Xun
    Payne, Richard J.
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2009, 38 (05): : 552 - 558
  • [22] Technology Insight: measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer
    Spencer, Carole A.
    LoPresti, Jonathan S.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (04): : 223 - 233
  • [23] Optimized Cutoff Value and Indication for Washout Thyroglobulin Level According to Ultrasound Findings in Patients with Well-Differentiated Thyroid Cancer
    Jung, J. Y.
    Shin, J. H.
    Han, B. -K.
    Ko, E. Y.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2013, 34 (12) : 2349 - 2353
  • [24] TSH Level as Predictor of Differentiated Thyroid Cancer.
    Dorange-Recton, Anne
    Illouz, Frederic
    Triau, Stephane
    Mucci-Hennekinne, Stephanie
    Bizon, Alain
    Laboureau, Sandrine
    Dubois, Severine
    Rohmer, Vincent
    Rodien, Patrice
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [25] Technology Insight: measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer
    Carole A Spencer
    Jonathan S LoPresti
    Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 : 223 - 233
  • [26] The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer
    Aras, Guelseren
    Gultekin, Salih Sinan
    Kucuk, Nuriye Ozlem
    NUCLEAR MEDICINE COMMUNICATIONS, 2008, 29 (10) : 880 - 884
  • [27] Thyroglobulin and thyroglobulin antibodies on thyroxine suppressive therapy in patients with recurrence of well differentiated thyroid carcinoma
    Bogsrud, TV
    Bach-Gansmo, T
    Jorgensen, LH
    Bjoro, T
    Paus, E
    Heilo, A
    Aas, M
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S207 - S207
  • [28] Prognostic value of the serum thyroglobulin levels after the first radioiodine ablation in detecting persistent and recurrent disease in patients with differentiated thyroid carcinoma
    Topuz, O.
    Onsel, C.
    Gunes, B.
    Kabasakal, L.
    Sayman, H.
    Sonmezoglu, K.
    Kanmaz, B.
    Halac, M.
    Uslu, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S265 - S265
  • [29] POSTOPERATIVE THYROGLOBULIN LEVEL DETERMINATION TO FOLLOW UP PATIENTS WITH HIGHLY DIFFERENTIATED THYROID-CANCER
    SZANTO, J
    VINCZE, B
    SINKOVICS, I
    KARIKA, Z
    DAUBNER, K
    PETER, I
    KAZATSAY, I
    ECKHARDT, S
    ONCOLOGY, 1989, 46 (02) : 99 - 104
  • [30] Reoperation for Recurrent/Persistent Well-Differentiated Thyroid Cancer
    Pai, Sara I.
    Tufano, Ralph P.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2010, 43 (02) : 353 - +
12345